Market Access
Integrating market access considerations into biopharmaceutical asset investment decisions: Common pain points and best practices
The biopharmaceutical industry operates at the intersection of health …
19724 items found
News
First rare disease therapies chosen for FDA START programme
An initiative set up by the FDA to accelerate the development of …
News
ASCO: KRAS upstarts set their sights on NSCLC market
There are already two drugs on the market targeting KRAS mutations, …
News
Cyberattack disrupts patient care at London hospitals
NHS hospitals in London have declared a critical incident caused by a …
News
FDA panel votes against Lykos’ pioneer psychedelic therapy
FDA independent advisors have comprehensively voted against the use …
R&D
Advancing innovation in life sciences R&D and Quality: Towards a single source of truth
This year’s Veeva R&D and Quality Summit saw full-house attendance at …
Oncology
Sales & Marketing
Partner Content
Diversity and Inclusion Interest Group Survey
Your industry needs you for the PM Society Diversity, Equity, and …
News
Bayer taps Samsung wearables for menopause sleep study
Sleep disturbances are one of the most common and disruptive symptoms …
News
ASCO: Moderna may file melanoma vaccine on phase 2b data
New data from a phase 2b trial of Moderna and MSD’s neoantigen …
News
Abbott’s OTC glucose monitor ‘will grow the market’
Just a few weeks after Dexcom’s Stelo became the first …
Digital
Key takeaways from ViVE: AI, security concerns, and industry transactions take centre stage
ViVE always offers an excellent opportunity to register the pulse of …
Patients
Gilead's HIV success and controversy: Expanding access amid ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
